Literature DB >> 21559746

Heart rate affects endothelial function in essential hypertension.

Raffaele Maio1, Sofia Miceli, Angela Sciacqua, Giulia Galiano Leone, Rosamaria Bruni, Paola Naccarato, Francesco Martino, Giorgio Sesti, Francesco Perticone.   

Abstract

Increased heart rate (HR) is a risk factor for cardiovascular morbidity and mortality in the general population and in some clinical conditions. Endothelial dysfunction is an adverse prognostic factor for cardiovascular events. The aim of the study was to evaluate the effect of HR on central hemodynamic parameters and endothelial function in hypertension. We evaluated forearm blood flow (FBF) response to intra-arterial infusion of acetylcholine (ACh) and sodium nitroprusside (SNP) in 30 patients with HR ≤60 min(-1) and 30 with HR ≥80 min(-1). The FBF was measured by strain-gauge plethysmography. Transesophageal atrial pacing was used to increase the HR. Radial artery applanation tonometry and pulse wave analysis were used to derive central aortic pressures and correlate hemodynamic indices. The FBF response to ACh is lower in hypertensives with HR ≤60 min(-1) than in those with HR ≥80 min(-1) (10.6 ± 4.2 vs. 13.6 ± 5.1 ml × 100 ml(-1) of tissue × min(-1), P < 0.001). Vascular resistance decreases to 9.3 ± 2.8 U in patients with lower HR versus 7.2 ± 2.1 U in those with higher HR (P = 0.002). The FBF response to SNP is similar in both groups. Central systolic and pulse pressure are higher in bradycardic patients than in those with HR ≥80 min(-1) (140 ± 8 vs. 131 ± 8 mmHg, P = 0.0001 and 49 ± 10 vs. 39 ± 11 mmHg, P = 0.0001). All central hemodynamic parameters decrease during incremental atrial pacing. Augmentation index is the strongest predictor of endothelial dysfunction at multivariate analysis. These findings demonstrate that low HR affects endothelium-dependent vasodilation in hypertension. Increased central aortic pressure and hemodynamic correlates seem to be the underlying mechanisms by which bradycardia interferes with endothelium-dependent reactivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559746     DOI: 10.1007/s11739-011-0618-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  37 in total

1.  Prognostic significance of endothelial dysfunction in hypertensive patients.

Authors:  F Perticone; R Ceravolo; A Pujia; G Ventura; S Iacopino; A Scozzafava; A Ferraro; M Chello; P Mastroroberto; P Verdecchia; G Schillaci
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Authors:  M A Creager; J P Cooke; M E Mendelsohn; S J Gallagher; S M Coleman; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients.

Authors:  F Perticone; R Maio; R Ceravolo; C Cosco; C Cloro; P L Mattioli
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

Review 5.  Vascular pathophysiology in response to increased heart rate.

Authors:  Florian Custodis; Stephan H Schirmer; Magnus Baumhäkel; Gerd Heusch; Michael Böhm; Ulrich Laufs
Journal:  J Am Coll Cardiol       Date:  2010-12-07       Impact factor: 24.094

6.  Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects.

Authors:  J C Chambers; P M Ueland; M Wright; C J Doré; H Refsum; J S Kooner
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

7.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

8.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

9.  Prevalence and determinants of cardiac and vascular hypertrophy in hypertension.

Authors:  M J Roman; T G Pickering; R Pini; J E Schwartz; R B Devereux
Journal:  Hypertension       Date:  1995-08       Impact factor: 10.190

10.  Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.

Authors:  Sharon M L Wallace; Carmel M McEniery; Kaisa M Mäki-Petäjä; Anthony D Booth; John R Cockcroft; Ian B Wilkinson
Journal:  Hypertension       Date:  2007-05-14       Impact factor: 10.190

View more
  2 in total

Review 1.  Aortic valve: mechanical environment and mechanobiology.

Authors:  Sivakkumar Arjunon; Swetha Rathan; Hanjoong Jo; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2013-03-21       Impact factor: 3.934

2.  Endothelial microparticle-associated protein disulfide isomerase increases platelet activation in diabetic coronary heart disease.

Authors:  Xiao-Di Sun; Lu Han; Hong-Tao Lan; Ran-Ran Qin; Ming Song; Wei Zhang; Ming Zhong; Zhi-Hao Wang
Journal:  Aging (Albany NY)       Date:  2021-07-20       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.